Atyr Pharma Inc (LIFE) Ordinary Shares

Sell:$1.57Buy:$1.69$0.03 (1.57%)

Prices delayed by at least 15 minutes
Sell:$1.57
Buy:$1.69
Change:$0.03 (1.57%)
Prices delayed by at least 15 minutes
Sell:$1.57
Buy:$1.69
Change:$0.03 (1.57%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
6 February 2024
Jill Marie BroadfootCFO
Sell
Tax related
1,590$1.69$2,687.1020,821
12 December 2023
Sanjay S. ShuklaPresident/CEO
Buy
Regular purchase transaction
12,000$1.18$14,136.00106,173
11 December 2023
Sanjay S. ShuklaPresident/CEO
Buy
Regular purchase transaction
3,000$1.17$3,510.0094,173
13 November 2023
Sanjay S. ShuklaPresident/CEO
Buy
Regular purchase transaction
13,578$1.11$15,085.1691,173
10 November 2023
Sanjay S. ShuklaPresident/CEO
Buy
Regular purchase transaction
1,422$1.14$1,618.2477,595
28 July 2023
Sanjay S. ShuklaPresident/CEO
Buy
Regular purchase transaction
15,000$2.01$30,223.5076,173
10 May 2023
Paul Reinhard SchimmelOther Level A
Buy
Regular purchase transaction
200,000$2.25$450,000.00313,023

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 May 2023
Paul Reinhard SchimmelOther Level A
Buy
Regular purchase transaction
200,000$2.25$450,000.00313,023
28 July 2023
Sanjay S. ShuklaPresident/CEO
Buy
Regular purchase transaction
15,000$2.01$30,223.5076,173
13 November 2023
Sanjay S. ShuklaPresident/CEO
Buy
Regular purchase transaction
13,578$1.11$15,085.1691,173
12 December 2023
Sanjay S. ShuklaPresident/CEO
Buy
Regular purchase transaction
12,000$1.18$14,136.00106,173
11 December 2023
Sanjay S. ShuklaPresident/CEO
Buy
Regular purchase transaction
3,000$1.17$3,510.0094,173

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.